Precision Biosciences, Inc. · NASDAQ:DTIL
Weinstein Benjamin reported a 5.20% stake in Precision Biosciences, Inc. (Schedule 13G)
Event Mar 18, 2025 · Filed Mar 18, 2025
Weinstein Benjamin reported a 5.20% stake in Precision Biosciences, Inc., 395,489 shares, as a passive investor on Mar 18, 2025. Filed Mar 18, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 395,489
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Weinstein Benjamin | 5.20% | 395,489 |
Source
Related
- Precision Biosciences, Inc.
- Weinstein Benjamin
- Precision Biosciences, Inc. shareholders
- Schedule 13G/A · Weinstein Benjamin · Aug 24, 2026
- Form 4 · Frankel Stanley · Sep 30, 2026
- Form 4 · Brown Melinda · Sep 29, 2026
- Form 4 · Germano Geno J · Sep 29, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jul 29, 2026
- Schedule 13G · Lynx1 Capital Management LP · Jul 20, 2026